A Study of LY2228820 in Participants With Advanced Cancer

Clinical trial NCT01393990 · COMPLETED

Trial details

NCT number: NCT01393990
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-09-04
Primary completion: 2013-02-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.